Pulmonary Arterial Hypertension (PAH)

DBCOND0039281Cardiovascular DiseasesRespiratory Tract Diseases

Pulmonary Arterial Hypertension (PAH) is the indication for 8 drugs in DrugBank. It is covered by 16 curated, structured indications.

Also known as
Pulmonary Arterial Hypertension · Pulmonary Artery Hypertension · PAH · Pulmonary Arterial Hypertention · Pulmonary Arterial Hypertension (CHD)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000649540SNOMED CT11399002MedDRA10064911UMLSC2973725

What you can answer from here — as of October 25, 2026

8Indicated drugsWith each drug's targets and mechanism
Listed above
16Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
480Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
1Boxed warningLabel boxed warnings that name this condition
Sign in
11Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Pulmonary Arterial Hypertension (PAH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In